by Kevin Cross | Sep 3, 2025 | In Silico Insider
N-Nitrosamine impurities in pharmaceuticals are assessed under the ICH M7 guideline where they are classified as a cohort of concern. Recently, structure-activity relationships (SAR) and read-across 2,3 approaches have been recommended for the determination of...
